Navigation Links
Beckman Coulter Signs Agreements With Amerinet, Inc.; Ten-Year Partnership Extended for Another Three Years
Date:10/30/2007

FULLERTON, Calif., Oct. 30 /PRNewswire-FirstCall/ -- Beckman Coulter, Inc. (NYSE: BEC), a leading manufacturer of diagnostics instruments in the U.S., announced that it has been awarded new agreements with Amerinet, Inc., to provide a full range of core laboratory systems and supplies, valued at approximately $74 million per year. Amerinet is one of the nation's largest healthcare group purchasing organizations, with more than 2,200 acute-care hospital members.

(Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO)

Under the terms of the new three-year agreements, Amerinet members will continue to purchase automation, general chemistry, immunoassay, integrated workcells, hematology, flow cytometry, and coagulation products from Beckman Coulter. Beckman Coulter and Amerinet have been partners since 1997.

In making the decision, Amerinet cited Beckman Coulter's ability to deliver resources and solutions that can enhance their members' ability to deliver quality patient care. They also pointed out Beckman Coulter's reputation for quality and responsive service as important to their members' satisfaction.

Leland Mc Arthy, corporate vice president of North America Commercial Operations for Beckman Coulter, said about the contract renewal, "These agreements are a great opportunity to continue to demonstrate our commitment to improving patient health and reducing the cost of care. Our systems simplify and automate laboratory processes, helping to improve the efficiency of Amerinet members."

Systems include Beckman Coulter's market-leading Power Processor Automation Systems and UniCel(R) DxC 800 and DxC 600 Synchron(R) Clinical Systems, as well as high-throughput UniCel DxI 800 Access(R) Immunoassay Systems and integrated UniCel DxC 600i Clinical Systems, which offer one of the broadest menus available today on a single instrument. Cellular analysis systems include state-of-the-art COULTER(R) LH 780 Hematology Analyzers, fully automated ACL* TOP hemostasis systems with optional closed-tube sampling, and the powerful FC 500 Flow Cytometry Systems, the only flow cytometer selected by Amerinet for its members.

About Amerinet, Inc.

Through Total Spend Management Solutions, Amerinet strategically partners with health care providers to improve operating margins by creating efficiencies, reducing costs and identifying new revenue streams. Supported by a team of clinical, data and supply chain experts, Amerinet offers a suite of tools, programs and services including a comprehensive and competitive portfolio that delivers practical solutions to address members' specific needs. Based in St. Louis, Mo, Amerinet serves more than 24,000 acute and non-acute health care providers nationwide. To learn more, visit http://www.amerinet- gpo.com.

About Beckman Coulter, Inc.

Based in Fullerton, California, Beckman Coulter develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue consisting of supplies, test kits, service and operating-type lease payments represents more than 75 percent of the company's 2006 annual revenue of $2.53 billion. For more information, visit http://www.beckmancoulter.com.

*ACL is a registered trademark of Instrumentation Laboratory

Contacts: Mary Luthy, Beckman Coulter Robert Raynor, Beckman Coulter

Corporate Communications Investor Relations

(714) 993-8770 (714) 773-7620


'/>"/>
SOURCE Beckman Coulter, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Related medicine news :

1. Filtration treatment assigns more live kidney donation
2. Depressed women show signs of earlier onset of Perimenopause
3. More signs to an approaching migraine attack
4. An Indian Bride with signs of SARS
5. Recognize Heart Attack Signs
6. Parents Should Look For Signs Of Children Becoming Overweight
7. Early Warning Signs Of Heart Disease
8. Warning Signs On Powered Baby Milk
9. Genetical Screening Can Detect Early Signs Of Multiple Sclerosis
10. Diagnosis of Alzheimers years before clinical signs emerge
11. President and Founder of National Obesity Forum Resigns
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... ... , ... As a former supermodel known for her timeless beauty, Joan Severance ... women is that she put all the words in her new book, "Manifest Your ... experiences and sparkling sense of humor have inspired her to write a book on ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... become familiar. This makes it difficult for lab operators and management to assess ... to help them identify wasteful or unnecessary actions. , Created with the ...
(Date:4/24/2017)... ... April 24, 2017 , ... A new ... the last decade, student well-being has seriously declined. "When disenfranchised youth from the ... join the Islamic State to turn the historic multi-ethnic and multi-religious powerhouses of ...
(Date:4/24/2017)... ... April 24, 2017 , ... “Learning to Use Your SPIRITUAL COMPASS ... “Learning to Use Your SPIRITUAL COMPASS To Navigate Life Issues” is the creation of ... Chairman of the Board of Directors for CONTACT USA, and former member of the ...
(Date:4/24/2017)... ... 24, 2017 , ... Miami Periodontist and Dental ... Reconstruction Foundation’s 2017 Symposium on Tissue Regeneration and Implant Dentistry held in Miami ... Global Symposium at the Fontainebleau Hotel located in Miami Beach, FL. This annual ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 The Global Effective Microorganisms (EM) ... report has covered and analysed the potential of Global Effective ... size, shares and growth factors. The report identifies and analyses ... in the global market. ... Browse 152 Tables and Figures, 6 Major Company Profiles, spread ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-naïve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 2017 Viverae ® , a leader in ... of IBM ® Watson Campaign Automation, implementing behavioral ... for a personalized experience. Through digital engagement, the platform ... in real time. The enhanced experience drives engagement by ... wherever they are in their journey to health. ...
Breaking Medicine Technology: